| Long name: |
NMDAR 2C Primary Polyclonal Antibody |
| Also known as: |
NMDAR 2C PAb |
| Category: |
Primary Antibodies |
| Conjugation: |
Unconjugated |
| Target Antigen: |
NMDAR2C |
| Specificity: |
This antibody may also recognize NMDAR 2D due to high sequence similarity, This is a highly specific antibody against NMDAR2C |
| Modification(s): |
None |
| Modification site(s): |
Unmodified antibody |
| Clonality: |
Polyclonal antibody |
| Clone number: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Immunogen range: |
500-550/1482 |
| Subcellular location: |
Extracellular |
| Source: |
This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human NMDAR2C |
| Gene ID number: |
2905 |
| Swiss Prot: |
Q14957 |
| Tested Applications: |
IF(IHC-P), IHC-P, WB |
| Recommended dilutions: |
IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity: |
Mouse, Rat, Human |
| Cross reactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen: |
Mediated by glycine, NMDA receptor subtype of glutamate-gated ion channels with high calcium permeability and voltage-dependent sensitivity to magnesium |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names: |
GRIN2C, GluN2C, Glutamate [NMDA] receptor subunit epsilon-3, Glutamate receptor ionotropic, N-methyl D-aspartate receptor subtype 2C, NMDA 2C, NMDAR2C, NR2C |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
NMDAR 2C |
| Short name: |
NMDAR 2C Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
NMDAR 2C (Antibody to) |
| Alternative technique: |
antibodies |